|
Cardiff Institute of Tissue Engineering and
Repair
University of Wales, Cardiff
Professor Keith Harding
Senior Researchers from Cardiff University and the University of Wales
College of Medicine have joined forces to form an international centre
in tissue engineering, called the Cardiff Institute of Tissue Engineering
and Repair (CITER).
This pioneering new institute, which was launched in March 2003 by the
First Minister of the Welsh Assembly Government, the Rt Hon Rhodri Morgan
AM, will concentrate on promoting research, education and clinical practice
in the field of tissue engineering and repair. In turn, this will lead
to the development of technological advances that will help with the diagnosis
and treatment of a widening number of clinical conditions associated with
tissue regeneration – such as ocular repair, osteoarthritis, sports
injuries, chronic wounds and kidney disease.
While there are several tissue repair research centres in the UK, CITER
is by far the biggest, boasting excellence in both basic science and clinical
research. The Institute possesses world-class basic science expertise
in the field of stem cells, polymer therapeutics, matrix biology, diagnostics
and medical engineering. On the clinical side, CITER’s strengths
exist in the fields of musculoskeletal injury, dermal wounds, progression
of kidney disease/ peritoneal host defence and eye disease. This high
level of expertise within CITER provides a vibrant research culture in
which to foster interdisciplinary research into tissue engineering and
repair.
CITER Team investigating corneal transparency, dioptic
power
and their alterations in pathological conditions. |
CITER is also unique in the way that it brings basic research scientists
together with practising clinicians. This close interaction between clinical
and basic scientists allows continuity of research from a laboratory setting
through models of disease to the clinical application of research findings
- ultimately leading to improved healthcare provision and enhanced quality
of life for patients. This is a particular feature in the disciplines
of renal disease and dermal wound healing. The dermal wound healing clinic
in Cardiff is the largest of its kind worldwide, where some 2500 patients
are seen annually. In addition, some 3500 acute facial wounds are seen
in the Dental clinics annually.
In conjunction with the technological developments and basic research
in the area of tissue engineering and repair, CITER will build on existing
taught courses at Cardiff (e.g., MSc in Wound Healing and Tissue Repair,
MSc in Clinical Engineering, MSc in Orthopaedic Engineering, and MSc in
Implantology) and facilitate multi-disciplinary research and education
through the development of new courses. CITER will also play a significant
role in lifelong learning and training.
Currently, the Institute has a total research income of £17 million
from Government, Research Councils, Charities and Industries and involves
over sixty Postdoctoral Research Fellows and eighty PhD students. Examples
of ongoing tissue engineering projects include: the development of wound
diagnostics, functional studies of bacterial biofilms and healing of chronic
wounds, the development of synthetic replacement for use in cartilage
repair, and the investigation of intercellular trafficking of polymeric
viral mimetics designed for intracytoplasmic delivery of gene and oligonucleotide
therapeutics.
For further information contact:
Professor Keith Harding
Cardiff Institute of Tissue Engineering and Repair
University of Wales College of Medicine
Cardiff Medicentre, Heath Park, Cardiff, CF14 4UJ
Tel: + 44 (0)2920 682 097, Fax: + 44 (0)2920 682 097
E-mail: hardingkg@whru.co.uk
or: grovesg@cf.ac.uk
Website: www.citer.org
|